OCD Trial, Recruiting NCT04725409 Sponsor: Vanderbilt University Medical Center Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT04725409
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are having a specific type of brain monitoring procedure (called SEEG) at Vanderbilt University Medical Center
  • You are 18 years of age or older
  • You are able to speak and understand English

Who may not be able to join:

  • You are under 18 years of age
  • You are not able to complete questionnaires, for example if you have difficulty understanding instructions or following directions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sarah Bick, MD, Vanderbilt University Medical Center

Phone: 615-421-3046

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
31 March 2021
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Neural activity correlating with the Center for Epidemiologic Studies Depression Scale - Revised (CESD-R); Neural activity correlating with the State-Trait Anxiety Inventory (STAI); Neural activity correlating with the Yale-Brown Obsessive Compulsive Scale (YBOCS); Neural activity correlating with the Barratt Impulsiveness Scale (BIS11); Local field potential changes in response to study tasks; Behavioral performance changes with stimulation; Single unit neuronal spiking changes in response to study tasks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov